A murine model for the assessment of placental and fetal development in teratogenicity studies.
During normal pregnancy in the mouse, maternal serum levels of the analogues to human schwangerschaftsprotein-1 and alpha-fetoprotein correlate significantly with the growth of the placenta and fetus respectively. This relationship has been utilized in the analysis of the effect of sodium selenite on placental and fetal growth in mice. Moderate doses of sodium selenite did not affect the growth of the placenta and fetus significantly, whereas high doses of selenite resulted in a large percentage of abortions. The protein markers were found to be useful in the prediction of placental and fetal growth, and they are suggested to be of general use in the study of the impact of teratogenic substances, since they reflect the status of the fetoplacental mass during gestation.
D000014:Abnormalities, Drug-Induced / Q000662:veterinary*; D000284:Administration, Oral; D000818:Animals; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D051379:Mice; D010920:Placenta / Q000187:drug effects*; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000502:physiology*; D011268:Pregnancy-Specific beta 1-Glycoproteins / Q000502:physiology*; D020887:Selenious Acid; D012643:Selenium / Q000008:administration & dosage / Q000633:toxicity*; D000509:alpha-Fetoproteins / Q000502:physiology*
D011257:Pregnancy Proteins; D011268:Pregnancy-Specific beta 1-Glycoproteins; D000509:alpha-Fetoproteins; D020887:Selenious Acid; D012643:Selenium